Cite
HARVARD Citation
Wahner Hendrickson, A. et al. (n.d.). 2022-RA-464-ESGO A phase i dose escalation and expansion cohort trial of carboplatin and gemcitabine with the ATR inhibitor berzosertib in first or second recurrence platinum sensitive epithelial ovarian, peritoneal, and fallopian tube cancer. International journal of gynecological cancer. pp. A237-A238. [Online].